Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus

Journal of Neurochemistry

Volumn 66, Issue 2, 1996, Pages 599-603

  Engleman, Eric A ^a   Robertson, David W ^a   Thompson, Dennis C ^a   Perry, Kenneth W ^a   Wong, David T ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT1A antagonist; 5 HT1A receptors; Duloxetine; Extracellular monoamines; Hypothalamus; LY 206130

Indexed keywords

1 CYCLOHEXYLAMINO 3 (1H INDOL 4 YLOXY) 2 PROPANOL MALEATE; CITALOPRAM; DULOXETINE; LY 206130; METITEPINE; PENBUTOLOL; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOPAMINE UPTAKE; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; HUMAN; HYPOTHALAMUS; MALE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SEROTONIN BLOOD LEVEL;

ANIMALS; BIOGENIC MONOAMINES; CYCLOHEXYLAMINES; DRUG SYNERGISM; EXTRACELLULAR SPACE; HYPOTHALAMUS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

ANIMALIA; TRIXIS;

EID: 0029670631     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66020599.x     Document Type: Article

References (27)

1. Adell A. and Artigas F. (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch. Pharmacol. 343, 237-244.
2. Artigas F., Perez V., and Alvarez E. (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors [letter]. Arch. Gen. Psychiatry 51, 248-251.
3. Beedle E. E., Robertson D. W., and Wong D. T. (1991) Serotonin antagonists. U.S. Patent no. 5,013,761, May 7, 1991.
4. Bel N. and Artigas F. (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmacol. 229, 101-103.
5. Blier P. and Bergeron R. (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15, 217-222.
6. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1, 470-480.
7. Blier P. and de Montigny C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226.
8. Blier P. Chaput Y., and de Montigny C. (1988) Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 337, 246-254.
9. Engleman E. A., Perry K. W., and Wong D. T. (1995) Simultaneous increase of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor. Neuropsychopharmacology 12, 287-295.
10. Fuller R. W., Hemrick-Luecke S. K., and Snoddy H. D. (1994) Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice. J. Pharmacol Exp. Ther. 269, 132-136.
11. 1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacology (Berlin) 91, 500-505.
12. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 60, 776-779.
13. 1A autoreceptors in the action of selective serotonin uptake inhibitors (SSRI). Eur. J Pharmacol. 260, 251-255.
14. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)-penbutolol. J. Pharmacol Exp. Ther. 265, 707-712.
15. Invernizzi R., Belli S., and Samanin R. (1992) Citalopram's ability to increase extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584, 322-324.
16. Kreiss D. S. and Lucki I. (1994) Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269, 1268-1279.
17. 1C/2 receptors, MK212 (6-chloro-2-(1-piperazinyl)pyrazine). Soc. Neurosci. Abstr. 17, 407.
18. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd edit. Academic Press, London.
19. Perry K. W. and Fuller R. W. (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50, 1683-1690.
20. Rutter J. J. and Auerbach S. B. (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265, 1319-1324.
21. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol. 96, 283-290.
22. 1B receptor subtype ligands. Soc. Neurosci. Abstr. 11, 47.
23. Tian Y., Eaton J. J., Goudreau J. L., Lookingland K. J., and Moore K. E. (1993) Neurochemical evidence that 5-hydroxytryptaminergic neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus. Brain Res. 667, 215-221.
24. van der Maelen C. P., Matheson G. K., Wilderman R. C., and Patterson L. A. (1986) Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J. Pharmacol. 129, 123-130.
25. Wong D. T., Bymaster F. P., Mayle D. A., Reid L. R., Krushinski J. H., and Robertson D. W. (1993) LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology 8, 23-33.
26. 1A receptor. Soc. Neurosci. Abstr. 20, 1542.
27. Wozniak K., Pert A., and Linnoila M. (1992) Alterations in raphe and frontal cortex serotonin over-flow following focal and systemic administration of fluoxetine. Soc. Neurosci. Abstr. 18, 1525.